Sunday, August 10, 2025 | 02:07 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Jagsonpal Pharmaceuticals Ltd

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR)

06:23 PM, 21st Feb 2025

With reference to the above we wish to inform you that Company had received the warning letter dated February 05 2025 from USFDA regarding observations during the inspection of contract manufacturing facility of Jagsonpal.

More Jagsonpal Pharmaceuticals Ltd Announcements